- Peter Greenleaf, President and Chief Executive Officer of Aurinia, remains a Director
- Kevin Tang, President of Tang Capital Management, LLC, appointed as a Director
- The Board has accepted the conditional resignations of three directors who received less than majority support at the 2024 Annual General Meeting
The restructured Board consists of seven members: Jeffrey A. Bailey; Robert T. Foster, Pharm.D., Ph.D., DSc; Peter Greenleaf; David R.W. Jayne, M.D., FRCP, FRCPE, FMedSci; Jill Leversage; Karen Smith, M.D., Ph.D., MBA, LLM; and Kevin Tang.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.